Hexyl-1,1-dimethoxy-3-phenylprop-2-ene
Common Name: |
Hexyl-1,1-dimethoxy-3-phenylprop-2-ene |
IUPAC Name: |
1-[(E)-3,3-dimethoxyprop-1-enyl]-4-hexylbenzene |
Molecular Formula: |
C13H18O2 |
SMILES: |
CCCCCCC1=CC=C(C=C1)C=CC(OC)OC |
Inchi: |
1S/C17H26O2/c1-4-5-6-7-8-15-9-11-16(12-10-15)13-14-17(18-2)19-3/h9-14,17H,4-8H2,1-3H3/b14-13+ |
Inchi Key: |
JOGSEXPLVUGVOJ-BUHFOSPRSA-N |
Cas No: |
29896-45-5 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
206.28 |
Mass (g/mol) |
262.193 |
Molar Refractivity |
62.74 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
6 |
Rings |
1 |
TPSA |
18.46 |
Hetero Atoms |
2 |
Heavy Atoms |
15 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
362.00 to 363.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.000038 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.38 |
LogP |
4.442 |
iLOGP |
3.14 |
XLOGP3 |
2.93 |
WLOGP |
2.99 |
MLOGP |
2.72 |
ESOL Log S |
-2.86 |
ESOL Solubility (mg/ml) |
0.282 |
ESOL Solubility (mol/l) |
0.001 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.98 |
Ali Solubility (mg/ml) |
0.22 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.61 |
Silicos-IT Solubility (mg/ml) |
0.05 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.48 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
1.074 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
1 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
1 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.911 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
0 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
1 |
Aromatase Binding |
1 |
Estrogen Receptor Binding |
1 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
1 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |